PROBLEMS IN THE MANAGEMENT OF OPPORTUNISTIC INFECTIONS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

被引:41
作者
MASUR, H
机构
[1] The Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD
关键词
D O I
10.1093/infdis/161.5.858
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Opportunistic infections ultimately occur in most patients infected with human immunodeficiency virus (HIV) and are responsible for 90% ofdeaths. Over the decade since the acquired immunodeficiency syndrome (AIDS) was first recognized, important advances have been made in reducing the morbidity and mortality of opportunistic infections in patients infected with HIV. These include an improved understanding of the relationship between immunologic parameters and infection, allowing the occurrence of infectious complications to be more predictable; development of prophylactic regimens and chronic suppressive regimens that are effective, well tolerated, and convenient;and emphasis on earlier diagnosisand therapeutic intervention of those infectious processes that are not prevented. These advances have allowed the quality and duration of patient survival to improve during this decade, but they can also be anticipated to alter the spectrum of clinical manifestations that health care providers are going to see during this epidemic’s second decade. © 1990 by the University of Chicago. All rights reserved.
引用
收藏
页码:858 / 864
页数:7
相关论文
共 64 条
[1]   BILATERAL UPPER LOBE PNEUMOCYSTIS-CARINII PNEUMONIA IN A PATIENT RECEIVING INHALED PENTAMIDINE PROPHYLAXIS [J].
ABD, AG ;
NIERMAN, DM ;
ILOWITE, JS ;
PIERSON, RN ;
BELL, ALL .
CHEST, 1988, 94 (02) :329-331
[2]   TRIMETREXATE FOR THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
ALLEGRA, CJ ;
CHABNER, BA ;
TUAZON, CU ;
OGATAARAKAKI, D ;
BAIRD, B ;
DRAKE, JC ;
SIMMONS, JT ;
LACK, EE ;
SHELHAMER, JH ;
BALIS, F ;
WALKER, R ;
KOVACS, JA ;
LANE, HC ;
MASUR, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (16) :978-985
[3]   ECONOMIC AND POLICY IMPLICATIONS OF EARLY INTERVENTION IN HIV DISEASE [J].
ARNO, PS ;
SHENSON, D ;
SIEGEL, NF ;
FRANKS, P ;
LEE, PR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (11) :1493-1498
[4]  
BIGBY TD, 1986, AM REV RESPIR DIS, V133, P515
[5]  
BOZZETTE SA, 1989, 29TH INT C ANT AG CH, P283
[6]   PROGNOSTIC FACTORS AND LIFE EXPECTANCY OF PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND PNEUMOCYSTIS-CARINII PNEUMONIA [J].
BRENNER, M ;
OGNIBENE, FP ;
LACK, EE ;
SIMMONS, JT ;
SUFFREDINI, AF ;
LANE, HC ;
FAUCI, AS ;
PARRILLO, JE ;
SHELHAMER, JH ;
MASUR, H .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (05) :1199-1206
[7]   CRYPTOCOCCAL MENINGITIS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) - SUCCESSFUL TREATMENT WITH FLUCONAZOLE AFTER FAILURE OF AMPHOTERICIN-B [J].
BYRNE, WR ;
WAJSZCZUK, CP .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (03) :384-385
[8]   9-(1,3-DIHYDROXY-2-PROPOXYMETHYL) GUANINE (GANCICLOVIR) IN THE TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL-DISEASE WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
CHACHOUA, A ;
DIETERICH, D ;
KRASINSKI, K ;
GREENE, J ;
LAUBENSTEIN, L ;
WERNZ, J ;
BUHLES, W ;
KORETZ, S .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) :133-137
[9]   TUBERCULOSIS AND HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
CHAISSON, RE ;
SLUTKIN, G .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :96-100
[10]   INHALED OR REDUCED-DOSE INTRAVENOUS PENTAMIDINE FOR PNEUMOCYSTIS-CARINII PNEUMONIA - A PILOT-STUDY [J].
CONTE, JE ;
HOLLANDER, H ;
GOLDEN, JA .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (04) :495-498